Answers are grounded in this paper and cite their sources.
There are many conditions for which hyperbaric oxygen therapy (HBOT) is currently being used in an investigational manner. This paper is a focused review of some conditions where we believe a mechanistic perspective supports further study on its efficacy. Undersea and hyperbaric medicine is a field in need of greater effort to understand both basic mechanisms as well as clinical efficacy. It is of course a conundrum that to justify the effort and expense of basic studies one must have a clinical foundation suggesting that treatment has benefit. Clearly, the body of evidence supports additional studies on many disorders. It is also true that expansion of the field of indications requires performing a clinical investigation, but this is where HBOT is vulnerable. That is, there is strong temptation to apply a treatment like HBOT that poses so little risk of adverse effects. As physicians, we are always striving to ease human suffering. Unfortunately, it is very easy to fall into the trap of applying HBOT to any speculative condition where no effective treatment exists. This is the point at which those who practice undersea and hyperbaric medicine and those who are consultants should make the effort to apply a high degree of discernment based upon the published literature. In this way, the field can scientifically and ethically expand to provide a beneficial therapeutic option to a larger number of people who may have no other options in managing their disease.
No takes yet. Share an insight, caveat, or question.
Le et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: